Harmony Biosciences Holdings-by Deal Co to Pay Bioprojet License Fee of $25.5 Mln to Develop, Manufacture and Commercialize Tpm-1116 in U.S. and Latam
Harmony Biosciences Holdings-by Deal Co将支付2550万美元的生物项目许可费,用于在美国和拉美开发、制造和商业化Tpm-1116
Harmony Biosciences Holdings-by Deal Co to Pay Bioprojet License Fee of $25.5 Mln to Develop, Manufacture and Commercialize Tpm-1116 in U.S. and Latam
Harmony Biosciences Holdings-by Deal Co将支付2550万美元的生物项目许可费,用于在美国和拉美开发、制造和商业化Tpm-1116
使用浏览器的分享功能,分享给你的好友吧